Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)

SHA:688163 Revenue

Shanghai Serum Bio-Technology had revenue of 77.12M CNY in the quarter ending June 30, 2026, with 2.55% growth. This brings the company's revenue in the last twelve months to 199.60M, up 0.97% year-over-year. In the year 2025, Shanghai Serum Bio-Technology had annual revenue of 196.21M with 0.66% growth. That makes Shanghai Serum Bio-Technology the 31,376th largest company in the world by revenue and 5,023rd in China.

• Revenue (ttm): 199.60M
• Revenue Growth: +0.97%
• P/S Ratio: 18.04
• Revenue / Employee: 594.04K
• Employees: 336
• Market Cap: 3.60B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	196.21M	1.29M	0.66%
Dec 31, 2024	194.92M	4.77M	2.51%
Dec 31, 2023	190.14M	15.92M	9.14%
Dec 31, 2022	174.22M	-34.47M	-16.52%
Dec 31, 2021	208.69M	23.13M	12.47%

Data Source: S&P Global Market Intelligence Last updated: Aug 21, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 13, 2026

Data Sources Report a data error